(Q63403075)
Statements
A Double-Blind Randomised Placebo-Controlled Phase I/IIa Dose Titration Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine up to 30 mg vs Placebo BID in Subjects With Urinary Incontinence (English)
0 references
3 April 2018
0 references
28 February 2019
0 references
84
0 references
18 year
0 references
70 year
0 references